Literature DB >> 17375432

Controlling HIV among injecting drug users: the current status of harm reduction.

Alex Wodak.   

Abstract

HIV among injecting drug users is now a critical issue in global HIV control. Harm reduction strategies have been considered effective, safe and affordable for at least 15 years. In this article, based on a plenary presentation at the conference, Alex Wodak argues that the scientific debate about harm reduction is now over and that the paramount need is to overcome the conventional reliance on drug law enforcement, the major barrier to implementing harm reduction strategies in time and at sufficient scale.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17375432

Source DB:  PubMed          Journal:  HIV AIDS Policy Law Rev        ISSN: 1712-624X


  4 in total

1.  Exploring stakeholder perceptions of acceptability and feasibility of needle exchange programmes, syringe vending machines and safer injection facilities in Tijuana, Mexico.

Authors:  Morgan M Philbin; Andrea Mantsios; Remedios Lozada; Patricia Case; Robin A Pollini; Jorge Alvelais; Carl A Latkin; Carlos Magis-Rodriguez; Steffanie A Strathdee
Journal:  Int J Drug Policy       Date:  2008-10-28

2.  HIV prevention: What have we learned from community experiences in concentrated epidemics?

Authors:  Bruno Spire; Isabelle de Zoysa; Hakima Himmich
Journal:  J Int AIDS Soc       Date:  2008-10-01       Impact factor: 5.396

3.  A qualitative assessment of stakeholder perceptions and socio-cultural influences on the acceptability of harm reduction programs in Tijuana, Mexico.

Authors:  Morgan M Philbin; Remedios Lozada; María Luisa Zúñiga; Andrea Mantsios; Patricia Case; Carlos Magis-Rodriguez; Carl A Latkin; Steffanie A Strathdee
Journal:  Harm Reduct J       Date:  2008-11-20

4.  Exploring stakeholder perceptions of facilitators and barriers to using needle exchange programs in Yunnan Province, China.

Authors:  Morgan M Philbin; Zhang FuJie
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.